Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORTEX: Duloxetine vs Escitalopram in Fibromyalgia
NCT03487211Phase 3Completed
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
- Start
- Apr 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in fibromyalgia (FM), sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Started Apr 2018; status: completed.
02
Drugs
escitalopram
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT03487211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03487211.